Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains
Gustavo Del Real, Sonia Jiménez-Baranda, Rosa Ana Lacalle, Emilia Mira, Pilar Lucas, Concepción Gómez-Moutón, Ana C Carrera, Carlos Martínez-A, Santos Mañes, Gustavo Del Real, Sonia Jiménez-Baranda, Rosa Ana Lacalle, Emilia Mira, Pilar Lucas, Concepción Gómez-Moutón, Ana C Carrera, Carlos Martínez-A, Santos Mañes
Abstract
Human immunodeficiency virus (HIV)-1 infection depends on multiple lateral interactions between the viral envelope and host cell receptors. Previous studies have suggested that these interactions are possible because HIV-1 receptors CD4, CXCR4, and CCR5 partition in cholesterol-enriched membrane raft domains. We generated CD4 partitioning mutants by substituting or deleting CD4 transmembrane and cytoplasmic domains and the CD4 ectodomain was unaltered. We report that all CD4 mutants that retain raft partitioning mediate HIV-1 entry and CD4-induced Lck activation independently of their transmembrane and cytoplasmic domains. Conversely, CD4 ectodomain targeting to a nonraft membrane fraction results in a CD4 receptor with severely diminished capacity to mediate Lck activation or HIV-1 entry, although this mutant binds gp120 as well as CD4wt. In addition, the nonraft CD4 mutant inhibits HIV-1 X4 and R5 entry in a CD4(+) cell line. These results not only indicate that HIV-1 exploits host membrane raft domains as cell entry sites, but also suggest new strategies for preventing HIV-1 infection.
Figures
References
- Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:31–39.
- Brown, D., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:111–136.
- Harder, T., P. Scheiffele, P. Verkade, and K. Simons. 1998. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141:929–942.
- Rodgers, W., and J. Rose. 1996. Exclusion of CD45 inhibits activity of p56lck associated with glycolipid–enriched membrane domains. J. Cell Biol. 135:1515–1523.
- Gomez-Mouton, C., J. Abad, E. Mira, R. Lacalle, E. Gallardo, S. Jimenez-Baranda, I. Illa, A. Bernad, S. Mañes, and C. Martinez-A. 2001. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc. Natl. Acad. Sci. USA. 98:9642–9647.
- van der Goot, F., and T. Harder. 2001. Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin. Immunol. 13:89–97.
- Maddon, P., A. Dalgleish, J. McDougal, P. Clapham, R. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:333–348.
- Xavier, R., T. Brennan, Q. Li, C. McCormack, and B. Seed. 1998. Membrane compartimentalization is required for efficient T cell activation. Immunity. 8:723–732.
- Moore, J., A. Trkola, and T. Dragic. 1997. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9:551–562.
- Berger, E., R. Doms, E. Fenyo, B. Korber, D. Littman, J. Moore, Q. Sattentau, H. Schuitemaker, and J. Sodroski. 1998. A new classification for HIV-1. Nature. 391:240.
- Littman, D. 1998. Chemokine receptors: keys to AIDS pathogenesis? Cell. 93:677–680.
- Mellado, M., J. Rodriguez-Frade, S. Mañes, and C. Martinez-A. 2001. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol. 19:397–421.
- Mañes, S., R. Lacalle, C. Gomez-Mouton, G. del Real, E. Mira, and C. Martinez-A. 2001. Membrane raft microdomains in chemokine receptor function. Semin. Immunol. 13:147–157.
- Mañes, S., G. del Real, R. Lacalle, P. Lucas, C. Gomez-Mouton, S. Sanchez-Palomino, R. Delgado, J. Alcami, E. Mira, and C. Martinez-A. 2000. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 1:190–196.
- Liao, Z., L. Cimakasky, R. Hampton, D. Nguyen, and J. Hildreth. 2001. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses. 17:1009–1019.
- Khanna, K., K. Whaley, L. Zeitlin, T. Moench, K. Mehrazar, R. Cone, Z. Liao, J. Hildreth, T. Hoen, L. Shultz, et al. 2002. Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J. Clin. Invest. 109:205–211.
- Hammache, D., N. Yahi, M. Maresca, G. Pieroni, and J. Fantini. 1999. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J. Virol. 73:5244–5248.
- Hug, P., H. Lin, T. Korte, X. Xiao, D. Dimitrov, J. Wang, A. Puri, and R. Blumenthal. 2000. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J. Virol. 74:6377–6385.
- Xiao, X., L. Wu, T. Stantchev, Y. Feng, S. Ugolini, H. Chen, Z. Shen, J. Riley, C. Broder, Q. Sattentau, et al. 1999. Constitutive cell surface association between CD4 and CCR5. Proc. Natl. Acad. Sci. USA. 96:7496–7501.
- Kuhmann, S., E. Platt, S. Kozak, and D. Kabat. 2000. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J. Virol. 74:7005–7015.
- Mañes, S., E. Mira, C. Gómez-Moutón, R. Lacalle, P. Keller, J. Labrador, and C. Martínez-A. 1999. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J. 18:6211–6220.
- Sorice, M., T. Garofalo, R. Misasi, A. Longo, V. Mattei, P. Sale, V. Dolo, R. Gradini, and A. Pavan. 2001. Evidence for cell surface association between CXCR4 and ganglioside GM3 after gp120 binding in SupT1 lymphoblastoid cells. FEBS Lett. 506:55–60.
- Nguyen, D., and D. Taub. 2002. CXCR4 function requires membrane cholesterol: implications for HIV infection. J. Immunol. 168:4121–4126.
- Kozak, S., J. Heard, and D. Kabat. 2002. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J. Virol. 76:1802–1815.
- Pralle, A., P. Keller, E. Florin, K. Simons, and J. Hörber. 2000. Sphingolipid–cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J. Cell Biol. 148:997–1007.
- Lama, J., A. Mangasarian, and D. Trono. 1999. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9:622–631.
- Carrera, A., F. Sánchez-Madrid, M. López-Botet, C. Bernabeu, and M. De Landazuri. 1987. Involvement of the CD4 molecule in a post-activation event on T cell proliferation. Eur. J. Immunol. 17:179–186.
- Carrera, A., H. Paradis, L. Borlado, T. Roberts, and C. Martínez-A. 1995. Lck unique domain influences Lck specificity and biological function. J. Biol. Chem. 270:3385–3391.
- Malissen, B., N. Rebai, A. Liabeuf, and C. Mawas. 1982. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur. J. Immunol. 12:739–747.
- Mira, E., R. Lacalle, M. González, C. Gómez-Moutón, J. Abad, A. Bernad, C. Martínez-A., and S. Mañes. 2001. A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep. 2:151–156.
- Scheiffele, P., M. Roth, and K. Simons. 1997. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J. 16:5501–5508.
- Melkonian, K., A. Ostermeyer, J. Chen, M. Roth, and D. Brown. 1999. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J. Biol. Chem. 274:3910–3917.
- Crise, B., and J. Rose. 1992. Identification of palmitoylation sites on CD4, the human immunodeficiency virus receptor. J. Biol. Chem. 267:13593–13597.
- Chu, K., and D. Littman. 1994. Requirement for kinase activity of CD4-associated p56lck in antibody-triggered T cell signal transduction. J. Biol. Chem. 269:24095–24101.
- Bannert, N., D. Schenten, S. Craig, and J. Sodroski. 2000. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses. J. Virol. 74:10984–10993.
- Nokta, M., X. Li, J. Nichols, M. Mallen, A. Pou, D. Asmuth, and R. Pollard. 2001. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals. AIDS. 15:161–169.
- Derdeyn, C., J. Decker, J. Sfakianos, Z. Zhang, W. O'Brien, L. Ratner, G. Shaw, and E. Hunter. 2001. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor. J. Virol. 75:8605–8614.
- Bedinger, P., A. Moriarty, R. von Borstel, N. Donovan, K. Steimer, and D. Littman. 1988. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature. 334:162–165.
- Diamond, D., R. Finberg, S. Chaudhuri, B. Sleckman, and S. Burakoff. 1990. Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4. Proc. Natl. Acad. Sci. USA. 87:5001–5005.
- Puri, A., P. Hug, K. Jernigan, J. Barchi, H. Kim, J. Hamilton, J. Wiels, G. Murray, R. Brady, and R. Blumenthal. 1998. The neutral glycophingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA. 95:14435–14440.
- Zheng, Y.-H., A. Plemenitas, T. Linnemann, O. Fackler, and B. Peterlin. 2001. Nef increases infectivity of HIV via lipid rafts. Curr. Biol. 11:875–879.
- Ono, A., and E. Freed. 2001. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA. 98:13925–13930.
Source: PubMed